GlassScriptPhysician profile
Waqaar Ahmad
NPI 1639515034
$23,505.53
in general payments reported to CMS, 2019-2025
28 companies · $6,893 in 2025
The $6,893 reported for 2025 was more than what 87% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,796 · 2020: $612 · 2021: $655 · 2022: $301 · 2023: $1,182 · 2024: $12K · 2025: $6,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $4,525 · Travel and Lodging: $1,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,425.00 |
| Food and Beverage | $4,524.60 |
| Travel and Lodging | $1,191.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,785.00 | 2021-2025 | Venaseal, Ellipsys Vascular Access System, Silverhawk |
| Medtronic USA, INC. | $1,455.71 | 2019-2020 | |
| Medtronic Vascular, INC. | $926.99 | 2019-2020 | |
| Koya Medical, INC. | $446.27 | 2024 | Dayspring, Koya Medical |
| Tactile Systems Technology INC | $329.43 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Neurocrine Biosciences, INC. | $271.48 | 2023-2025 | Ingrezza, Ongentys |
| Angiodynamics, INC. | $166.62 | 2021-2025 | Venacure 1470 Pro |
| Tanabe Pharma America, INC. | $145.35 | 2024-2025 | Radicava |
| Penumbra, INC. | $131.91 | 2025 | Ruby Coil |
| Janssen Pharmaceuticals, INC | $124.59 | 2021-2023 | Xarelto |
| Nevro Corp. | $98.77 | 2021 | |
| Biogen, INC. | $75.41 | 2023 | Tysabri, Vumerity |
| Neurelis, INC. | $71.15 | 2023-2024 | Valtoco |
| Sk Life Science, INC. | $63.54 | 2023 | |
| Solventum Corporation | $62.97 | 2025 | Activ.A.C., Promogran Prisma |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $53.18 | 2024-2025 | Venclose Maven Catheter |
| Teva Pharmaceuticals USA, INC. | $41.57 | 2023-2025 | Austedo Xr, Austedo Xr |
| Urgo Medical North America, LLC | $36.85 | 2024 | Urgok2 |
| Celgene Corporation | $28.63 | 2024 | Zeposia |
| Philips North America LLC | $25.88 | 2019 | |
| Ucb, INC. | $23.92 | 2024 | Rystiggo |
| Eisai INC. | $23.59 | 2025 | |
| Alnylam Pharmaceuticals INC. | $23.41 | 2023 | Onpattro |
| Takeda Pharmaceuticals U.S.A., INC. | $20.67 | 2023 | |
| Ani Pharmaceuticals, INC. | $20.56 | 2024 | Purified Cortrophin Gel |
| Boston Scientific Corporation | $19.44 | 2022 | |
| Mimedx Group, INC. | $17.72 | 2025 | |
| Mallinckrodt Hospital Products INC. | $14.92 | 2023 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waqaar Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.